Pubblicazioni

Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement

2023 - JOURNAL OF CLINICAL MEDICINE

Fargnoli, M. C.; Bardazzi, F.; Bianchi, L.; Dapavo, P.; Fabbrocini, G.; Gisondi, P.; Micali, G.; Offidani, A. M.; Pellacani, G.; Skroza, N.; Angileri, R. G.; Burlando, M.; Campanati, A.; Carrera, C. G.; Chiricozzi, A.; Conti, A.; Simone, C. D.; Di Lernia, V.; Errichetti, E.; Galluzzo, M.; Guarneri, C.; Lasagni, C.; Lembo, S.; Loconsole, F.; Megna, M.; Musumeci, M. L.; Prignano, F.; Richetta, A. G.; Trovato, E.; Venturini, M.; Peris, K.; Pinton, P. C.

Interleukin-17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery following Secukinumab Administration

2023 - JOURNAL OF CLINICAL MEDICINE

Frustaci, Andrea; Galea, Nicola; Dominici, Lorenzo; Verardo, Romina; Alfarano, Maria; Scialla, Rossella; Richetta, Antonio Giovanni

Safety and impact of anti-COVID-19 vaccines in psoriatic patients treated with biologics. A real life experience

2021 - JOURNAL OF CLINICAL MEDICINE

Skroza, N.; Bernardini, N.; Tolino, E.; Proietti, I.; Mambrin, A.; Marchesiello, A.; Marraffa, F.; Rossi, G.; Volpe, S.; Potenza, C

Direct and indirect impact of covidâ19 for patients with immuneâmediated inflammatory diseases. A retrospective cohort study